![Nathan Bryson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nathan Bryson
Directeur Technique/Scientifique/R&D chez Reunion Neuroscience, Inc.
Postes actifs de Nathan Bryson
Sociétés | Poste | Début | Fin |
---|---|---|---|
Reunion Neuroscience, Inc.
![]() Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada. | Directeur Technique/Scientifique/R&D | 01/08/2022 | - |
Historique de carrière de Nathan Bryson
Anciens postes connus de Nathan Bryson
Sociétés | Poste | Début | Fin |
---|---|---|---|
REUNION NEUROSCIENCE | Directeur Technique/Scientifique/R&D | 01/03/2020 | 01/08/2022 |
ACERUS PHARMACEUTICALS CORPORATION | Directeur Technique/Scientifique/R&D | - | 06/03/2020 |
Corporate Officer/Principal | 01/02/2014 | - | |
CYNAPSUS THERAPEUTICS INC | Directeur Technique/Scientifique/R&D | 15/05/2009 | 22/01/2014 |
Bionisis SA
![]() Bionisis SA Medical SpecialtiesHealth Technology Bionisis SA distributes spearation instruments. The firm markets sorbent beds and accessories based on its patented OPLC technology(Optimum Performance Laminar ChromatographyTM). The firm provides solutions to chemists in the fields of organic synthesis, natural products, medicinal chemistry, drug discovery, lead optimization, toxicology, drug metabolism, forensic science, analytical development, chemical process R&D and manufacturing & quality control. The company was founded in 1999 and is headquartered in Le Plessis-Robinson, France | Directeur Technique/Scientifique/R&D | 02/12/2008 | 02/12/2008 |
Matregen Corp.
![]() Matregen Corp. Miscellaneous Commercial ServicesCommercial Services Matregen Corp. engaged in the development and commercialization of novel Drug Delivery Systems. Its SpinFX technology is a technique used to produce novel structures such as porous tubes, composites, and coatings. The company was founded by Dr. Molly S. Shoichet and Dr. Paul D. Dalton in 2002 and is headquartered in Toronto, Canada. | Directeur Technique/Scientifique/R&D | 01/01/2005 | 01/01/2007 |
Flamel Technologies SA
![]() Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | Fondateur | 01/01/1990 | 01/01/2002 |
Formation de Nathan Bryson
Massachusetts Institute of Technology | Doctorate Degree |
Auburn University | Undergraduate Degree |
Statistiques
Internationale
Canada | 6 |
Etats-Unis | 3 |
France | 3 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 6 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 6 |
Finance | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
![]() | Health Technology |
Entreprise privées | 6 |
---|---|
Bionisis SA
![]() Bionisis SA Medical SpecialtiesHealth Technology Bionisis SA distributes spearation instruments. The firm markets sorbent beds and accessories based on its patented OPLC technology(Optimum Performance Laminar ChromatographyTM). The firm provides solutions to chemists in the fields of organic synthesis, natural products, medicinal chemistry, drug discovery, lead optimization, toxicology, drug metabolism, forensic science, analytical development, chemical process R&D and manufacturing & quality control. The company was founded in 1999 and is headquartered in Le Plessis-Robinson, France | Health Technology |
Cynapsus Therapeutics, Inc.
![]() Cynapsus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cynapsus Therapeutics, Inc. operated as a pharmaceutical company, which developed an improved dosing formulation of an approved drug used to treat the symptoms of Parkinson's disease. The company was founded by Andrew Williams and David Hill on January 16, 2004 and was headquartered in Toronto, Canada. | Health Technology |
Acerus Pharmaceuticals Corp.
![]() Acerus Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Acerus Pharmaceuticals Corp. is a pharmaceutical company. The firm is focused on the commercialization and development of prescription products that improve patient experience, with a focus in the field of men’s health. It focuses on therapeutics for urology, andrology, and endocrinology. Its products include Estrace and Natesto. The company was founded by Bruce D. Brydon, Rolf K. Reininghaus and Mark L. Thompson on September 9, 2008 and is headquartered in Mississauga, Canada. | Health Technology |
Field Trip Health Ltd.
![]() Field Trip Health Ltd. Medical/Nursing ServicesHealth Services Field Trip Health Ltd. engages in development and delivery of technology-enabled psychedelic therapies. It offers psychedelic-enhanced and psychedelic-integration psychotherapy. The firm is developing patient-centric and evidence-based psychedelic approaches to behavioral and mental health. The company was founded by Joseph del Moral, Ronan Levy, Hannan Fleiman, Syed Mujeeb Jafferi, and Ryan Yermus on September 30, 2008 and is headquartered in Toronto, Canada. | Health Services |
Matregen Corp.
![]() Matregen Corp. Miscellaneous Commercial ServicesCommercial Services Matregen Corp. engaged in the development and commercialization of novel Drug Delivery Systems. Its SpinFX technology is a technique used to produce novel structures such as porous tubes, composites, and coatings. The company was founded by Dr. Molly S. Shoichet and Dr. Paul D. Dalton in 2002 and is headquartered in Toronto, Canada. | Commercial Services |
Flamel Technologies SA
![]() Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | Health Technology |
- Bourse
- Insiders
- Nathan Bryson
- Expérience